Results of three investigator-initiated trials on cadonilimab (PD-1/CTLA-4) for G/GEJC, pMMR/MSS mCRC, and HCC neoadjuvant therapy published at ESMO Asia 2023
First-line therapy for gastric cancer and metastatic colorectal cancer, neoadjuvant therapy for hepatocellular carcinoma HONGKONG, Dec. 5, 2023 /PRNewswire/ -- Akeso (9926.HK) published...
Nubank Cripto Integrates Talos's Smart Order Routing System to Reduce Trading Costs
Partnership makes access to liquidity providers even more efficient, offering better buying and selling prices in Brazilian reais for cryptocurrencies in the Nu app...
MFT KOREA opens direct transaction platform for automotive filters, 'we will accelerate global market entrance'
SEOUL, South Korea, Dec. 5, 2023 /PRNewswire/ -- MFT KOREA, a car filter manufacturing company, has opened its official website and started to expand...
Artists' Sub-Forum of "Liangzhu Forum" & "Silk Road Artists' Rendezvous" Exhibition Held in Liangzhu, Hangzhou
HANGZHOU, China, Dec. 5, 2023 /PRNewswire/ -- The inaugural Liangzhu Forum took place on December 3 in Hangzhou, east China's Zhejiang Province. That same...
Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Dec. 6, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries,...